SR

Sanjay Rajaram Dhanawade

Active Director Designated Partner DIN 10037227
DIN 10037227 First appointment Jan 2023 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Rajaram Dhanawade

Data last updated:

Sanjay Rajaram Dhanawade is a Designated Partner at Derma Face Pharmaceuticals Llp (since 2023). The company operates in Research & Development.

DIN 10037227
Primary Designation Designated Partner
Industry Research & Development
First Appointment 03 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Jan 20232023Active

Board colleagues of Sanjay Rajaram Dhanawade

Directorship timeline

Open interactive timeline →
Derma Face Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sanjay Rajaram Dhanawade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Rajaram Dhanawade

Sanjay Rajaram Dhanawade currently holds 1 directorship: Derma Face Pharmaceuticals Llp (Designated Partner, since 03 Jan 2023).

Sanjay Rajaram Dhanawade was first appointed on 03 Jan 2023 as Designated Partner at Derma Face Pharmaceuticals Llp.

The current boards of Sanjay Rajaram Dhanawade's companies include Ajit Bajirao Patil (Derma Face Pharmaceuticals Llp), Arvindkumar Harinarayan Shukla (Derma Face Pharmaceuticals Llp), Rakesh Sarathlal Saroj (Derma Face Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available